Adverse drug reaction deaths reported in United States vital statistics, 1999-2006;Décès suite aux effets indésirables rapportés aux États Unis en utilisant les statistiques de l'état civil entre 1999-2006

Annals of Pharmacotherapy

Volumn 46, Issue 2, 2012, Pages 169-175

  Shepherd, Greene ^a   Mohorn, Philip ^b   Yacoub, Kristina ^b   May, Dianne Williams ^b  

^a UNC Hamner Institute for Drug Safety Sciences   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Adverse drug reaction; Public health; Safety

Indexed keywords

ANABOLIC AGENT; ANALGESIC AGENT; ANDROGEN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ANTIPYRETIC AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; INSULIN; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL ANTIDIABETIC AGENT; PENICILLIN G; SEDATIVE AGENT; VITAMIN K GROUP;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHILD; DATA BASE; DEMOGRAPHY; DRUG FATALITY; DYING; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE; RURAL AREA; SCHOOL CHILD; UNITED STATES; UNSPECIFIED SIDE EFFECT; URBANIZATION; VITAL STATISTICS;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AFRICAN AMERICANS; AGED; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; DRUG TOXICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; RURAL POPULATION; UNITED STATES; YOUNG ADULT;

EID: 84857000847     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P592     Document Type: Article

References (21)

1. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004;140:795-801.
2. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: Institute of Medicine, 2000.
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
4. Bhasale A. The wrong diagnosis: identifying causes of potentially adverse events in general practice using incident monitoring. Fam Pract 1998;15:308-18.
5. Leape LL. Preventing adverse drug events. Am J Health Syst Pharm 1995;52:379-82.
6. Chyka PA. How many deaths occur annually from adverse drug reactions in the United States? Am J Med 2000;109:122-30.
7. Stelfox HT, Palmisani S, Scurlock C, Orav EJ, Bates DW. The "To Err is Human" report and the patient safety literature. Qual Saf Health Care 2006;15:174-8.
8. Vital statistics of the United States: mortality, 1999 technical appendix. Hyattsville, MD: Centers for Disease Control and Prevention, 1999.
9. Roe CM, McNamara AM, Motheral BR. Gender-and age-related prescription drug use patterns. Ann Pharmacother 2002;36:30-9. DOI 10.1345/aph.1A113
10. Adler NE, Rehkopf DH. US disparities in health: descriptions, causes, and mechanisms. Annu Rev Public Health 2008;29:235-52.
11. Gaskin DJ, Briesacher BA, Limcangco R, Brigantti BL. Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries. Am J Geriatr Pharmacother 2006;4:96-111.
12. Harper M, Dugan E, Espeland M, Martinez-Borges A, McQuellon C. Why African-American women are at greater risk for pregnancy-related death. Ann Epidemiol 2007;17:180-5.
13. Hlaing WM. Race/ethnic disparity in hypertension-related hospitalization in Florida. Ethn Dis 2007;17:453-60.
14. Le Cook B, McGuire TG, Zuvekas SH. Measuring trends in racial/ethnic health care disparities. Med Care Res Rev 2009;66:23-48.
15. Rutledge MS, McLaughlin CG. Hispanics and health insurance coverage: the rising disparity. Med Care 2008;46:1086-92.
16. Yang JJ, Burchard EG, Choudhry S, et al. Differences in allergic sensitization by self-reported race and genetic ancestry. J Allergy Clin Immunol 2008;122:820-7, e9.
17. Arias E, Schauman WS, Eschbach K, Sorlie PD, Backlund E. The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 2 2008;148:1-23.
18. Thomas EJ, Orav EJ, Brennan TA. Hospital ownership and preventable adverse events. Int J Health Serv 2000;30:745-61.
19. Wester K, Jonsson AK, Spigset O, Druid H, Hagg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 2008;65:573-9.
20. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995;10:199-205.
21. Gandhi TK, Weingart SN, Seger AC, et al. Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med 2005;20: 837-41.